Feb 4 (Reuters) - Novo Nordisk said on Wednesday it will launch some doses of its oral semaglutide for diabetes under the ...

A Novo executive noted that many customers are unaware that the company already makes oral semaglutide for type 2 diabetes ...

Ozempic, a semaglutide drug originally developed for type-2 diabetes, has been in the news as a fast-track weight-loss solution. A former AIIMS dietitian, took to X (twitter) to reveal that while ...

How to Get Prescribed Ozempic for Weight Loss This article was reviewed by Lynn Marie Morski, MD, JD Ozempic is FDA-approved for type 2 diabetes but sometimes prescribed ...

With a U.S. Food and Drug Administration ban on copycat semaglutide drugs now in effect, Novo Nordisk is launching a series of initiatives to improve access to authentic versions of its blockbuster ...

Ozempic has become so embedded in global culture that “Ozempic face” was shortlisted for a prominent dictionary’s word of the ...

Once-weekly CagriSema significantly reduced HbA1c and body weight vs semaglutide in patients with type 2 diabetes in the REIMAGINE 2 trial.

Sun Pharma has received approval from the Drugs Controller General of India to manufacture and market a generic version of semaglutide injection. Semaglutide, a glucagon-like peptide-1 receptor ...

Once-weekly semaglutide significantly reduces hospital admissions and total hospital stay in patients with CVD and obesity.